Discontinuation of Everolimus Due to Related and Unrelated Adverse Events in Cancer Patients: A Meta-Analysis
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Investigation"
DOI: 10.1080/07357907.2017.1344697
Abstract: ABSTRACT A meta-analysis of randomized controlled trials (RCTs) was performed to examine the risk of everolimus discontinuation due to related and unrelated adverse events (AE) in cancer patients. Fifteen RCTs were analyzed that compared everolimus… read more here.
Keywords: due related; everolimus; related unrelated; discontinuation ... See more keywords